Pablo Corral: “The lower, The better” Applies to The Brain Too
Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, posted on LinkedIn:
”Lower LDL-C, Lower Risk – Safely
New analysis from FOURIER & FOURIER-OLE (Monguillon et al., Circulation 2025):
In patients with prior ischemic stroke, achieving LDL-C <40 mg/dL led to a continuous reduction in MACE and recurrent stroke, without any increase in hemorrhagic stroke.
- 5,291 stroke patients
- Follow-up up to 7 years
- Stepwise reduction in cardiovascular and ischemic events with lower LDL-C
- Hemorrhagic strokes: rare and unrelated to LDL-C
Conclusion: Very low LDL-C levels (<40 mg/dL) are both effective and safe for secondary prevention after stroke – confirming that “the lower, the better” also applies to the brain.”
Read the full article here.
Title: Efficacy and Safety of Very Low Achieved LDL-Cholesterol in Patients with Prior Ischemic Stroke
Authors: Victorien Monguillon, Peter Kelly, Michelle L. O’Donoghue, Jeong-Gun Park, Erin A. Bohula, Jeffrey L. Saver, Dan Atar, Anthony C. Keech, Peter S. Sever, Huei Wang, Gabriel Paiva da Silva Lima, Marc S. Sabatine, Robert P. Giugliano

Stay updated with Hemostasis Today.
-
Feb 17, 2026, 16:34ISTH Names Five Global Recipients of 2026 Esteemed Career Awards
-
Feb 17, 2026, 16:16Flora Peyvandi: A Multicenter Initiative to Improve Guideline Adherence in Pediatric ITP
-
Feb 17, 2026, 16:14Hendrianus The: Intravenous Cangrelor in Hemodynamically Unstable Patients Undergoing PCI
-
Feb 17, 2026, 15:42Paul Wischmeyer: Nutrient Absorption in the GI Tract
-
Feb 17, 2026, 15:40Mahesan Subramaniam: Reversing Age-Related Decline in Blood Stem Cells
-
Feb 17, 2026, 15:38Wolfgang Miesbach: How a Single Mutation Can Flip Immunity into VITT
-
Feb 17, 2026, 15:34Jeff June: When Safety Warnings Outlive the Evidence – What Statins Teach Us About Stroke Prevention and Biology
-
Feb 17, 2026, 15:32Gabrielle Sarlon: Key Messages to Improve VTE Management in Women of Childbearing Age
-
Feb 17, 2026, 15:27Piezo1 Gain-of-Function Mutation Explains Thromboembolic Complications in Hereditary Xerocytosis – JTH